|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hsu ching sheng"
Showing items 1-25 of 79 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
| 中國文化大學 |
2022-09 |
A Loyalty System Incorporated with Blockchain and Call Auction
|
Tu, Shu-Fen; Hsu, Ching-Sheng; Wu, Yan-Ting |
| 中國文化大學 |
2022-05 |
Design of an e-diploma system based on consortium blockchain and facial recognition
|
Hsu, Ching-Sheng; Tu, Shu-Fen; Chiu, Pei-Chia |
| 中國文化大學 |
2021-09 |
Improving RE-SWOT analysis with sentiment classification: A case study of travel agencies
|
Tu, Shu-Fen; Hsu, Ching-Sheng; Lu, Yu-Tzu |
| 中國文化大學 |
2020-05-01 |
Correction to: Enhancing the robustness of image watermarking against cropping attacks with dual watermarks (Multimedia Tools and Applications, (2020), 79, 17-18, (11297-11323), 10.1007/s11042-019-08367-6)
|
Hsu, Ching-Sheng; Tu, Shu-Fen |
| 臺大學術典藏 |
2018-09-10T15:35:07Z |
Management of hepatitis C patients with decompensated liver disease
|
Hsu, Ching-Sheng;Kao, Jia-Horng; Hsu, Ching-Sheng; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:34:51Z |
Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang;Yang, Hung-Chih;Hsu, Ching-Sheng;Wang, Chih-Chiang;Wang, Tzu-San;Kao, Jia-Horng;Chen, Ding-Shinn; Liu, Wei-Liang; HUNG-CHIH YANG; DING-SHINN CHEN; Yang, Hung-Chih; Yang, Hung-Chih; JIA-HORNG KAO; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Chih-Chiang; Wang, Tzu-San; Wang, Tzu-San; Kao, Jia-Horng; Kao, Jia-Horng; Chen, Ding-Shinn |
| 臺大學術典藏 |
2018-09-10T15:34:49Z |
Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Liu, Wei-Liang;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; Hsu, Ching-Sheng; Hsu, Ching-Sheng; Chang, Chia-Hsuin; Hsu, Shih-Jer; Hsu, Shih-Jer; JIA-HORNG KAO; Liu, Wei-Liang; Liu, Wei-Liang; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T15:24:41Z |
Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection
|
Hsu, Ching-Sheng;Liu, Wei-Liang;Chao, You-Chen;Lin, Hans Hsienhong;Tseng, Tai-Chung;Wang, Chia-Chi;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; Hsu, Ching-Sheng; Liu, Wei-Liang; JIA-HORNG KAO; Chao, You-Chen; Lin, Hans Hsienhong; Abbas, Z.; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T14:59:23Z |
Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis
|
Wang, Chia-Chi;Hsieh, Tsung-Cheng;Tseng, Tai-Chung;Wang, Pin-Chao;Hsu, Ching-Sheng;Lin, Hans Hsienhong;Wang, Li-Yu;Kao, Jia-Horng; Wang, Chia-Chi; JIA-HORNG KAO; Hsieh, Tsung-Cheng; Tseng, Tai-Chung; Wang, Pin-Chao; Hsu, Ching-Sheng; Lin, Hans Hsienhong; Wang, Li-Yu; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T14:59:14Z |
A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Lin, Hans Hsienhong;Tseng, Tai-Chung;Wang, Chia-Chi;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; Hsu, Ching-Sheng; JIA-HORNG KAO; Hsu, Shih-Jer; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction?
|
Hsu, Ching-Sheng;Kao, Jia-Horng; Hsu, Ching-Sheng; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:49:32Z |
Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients
|
Hsu, Ching-Sheng; Huang, Chun-Jen; Kao, Jia-Horng; Lin, Hans Hsienhong; Chao, You-Chen; Fan, Yen-Chun; Tsai, Pei-Shan; Polis, Michael Alan; JIA-HORNG KAO; Hsu, Ching-Sheng; Huang, Chun-Jen; Kao, Jia-Horng; Kao, Jia-Horng; Lin, Hans Hsienhong; Lin, Hans Hsienhong; Chao, You-Chen; Fan, Yen-Chun; Fan, Yen-Chun; Tsai, Pei-Shan; Tsai, Pei-Shan; Polis, Michael Alan |
| 臺大學術典藏 |
2018-09-10T09:49:23Z |
IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Liu, Wei-Liang;Chen, Chi-Ling;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; Hsu, Ching-Sheng; PEI-JER CHEN; Hsu, Shih-Jer; Liu, Wei-Liang; DING-SHINN CHEN; Chen, Chi-Ling; JIA-HORNG KAO; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:47:27Z |
Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients
|
Hsu, Ching-Sheng;Hsu, Shih-Jer;Chen, Hung-Chia;Liu, Chen-Hua;Jeng, Jenher;Liu, Chun-Jen;Chen, Pei-Jer;Chen, Ding-Shinn;Kao, Jia-Horng; CHUN-JEN LIU; Hsu, Ching-Sheng; Hsu, Ching-Sheng; PEI-JER CHEN; Hsu, Shih-Jer; Hsu, Shih-Jer; CHEN-HUA LIU; Chen, Hung-Chia; Chen, Hung-Chia; Liu, Chen-Hua; DING-SHINN CHEN; Liu, Chen-Hua; Jeng, Jenher; JIA-HORNG KAO; Liu, Chun-Jen; Liu, Chun-Jen; Chen, Pei-Jer; Chen, Pei-Jer; Chen, Ding-Shinn; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T09:23:50Z |
Genomic variation-guided management in chronic hepatitis C
|
Hsu, Ching-Sheng;Kao, Jia-Horng; Hsu, Ching-Sheng; JIA-HORNG KAO; Kao, Jia-Horng; Kao, Jia-Horng |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
Hepatitis C virus and lipid profiles: More questions than answers?
|
Hsu, Ching-Sheng;Kao, Jia-Horng; HSU, CHING-SHENG;KAO, JIA-HORNG; 許景盛;高嘉宏; JIA-HORNG KAO; Hsu, Ching-Sheng; Liu, Wei-Liang; HSU, CHING-SHENG; Chao, You-Chen; KAO, JIA-HORNG; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信 |
| 臺大學術典藏 |
2018-09-10T08:44:32Z |
Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling
|
Hsu, Ching-Sheng;Jeng, Jenher;Kao, Jia-Horng;Chen, Ding-Shinn; DING-SHINN CHEN; JIA-HORNG KAO; HSU, CHING-SHENG; JENG, JENHER; KAO, JIA-HORNG; CHEN, DING-SHINN |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease
|
Wang, Chia-Chi;Lin, Shinn-Kuang;Tseng, Yuan-Fu;Hsu, Ching-Sheng;Tseng, Tai-Chung;Lin, Hans Hsien-Hong;Wang, Li-Yu;Kao, Jia-Horng; JIA-HORNG KAO; WANG, CHIA-CHI; LIN, SHINN-KUANG; TSENG, YUAN-FU; HSU, CHING-SHENG; TSENG, TAI-CHUNG; LIN, HANS HSIEN-HONG; WANG, LI-YU; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:49Z |
Esomeprazole for asthma [7]
|
Hsu, Ching-Sheng;Kao, Jia-Horng; JIA-HORNG KAO; HSU, CHING-SHENG; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T07:39:48Z |
Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease
|
Hsu, Ching-Sheng;Chen, Ding-Shinn;Kao, Jia-Horng; DING-SHINN CHEN; JIA-HORNG KAO; HSU, CHING-SHENG; CHEN, DING-SHINN; KAO, JIA-HORNG |
| 國立臺灣大學 |
2016 |
Management of hepatitis C patients with decompensated liver disease
|
Hsu, Ching-Sheng; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2016 |
Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy
|
Hsu, Ching-Sheng; Hsu, Shih-Jer; Liu, Wei-Liang; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏; 徐士哲 |
| 國立臺灣大學 |
2016 |
Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway
|
Liu, Wei-Liang; Yang, Hung-Chih; Hsu, Ching-Sheng; Wang, Chih-Chiang; Wang, Tzu-San; Kao, Jia-Horng; Chen, Ding-Shinn; 陳定信; 高嘉宏; 楊宏志 |
| 國立臺灣大學 |
2016 |
HIV/HCV Coinfection in Taiwan
|
Hsu, Ching-Sheng; Kao, Jia-Horng; 高嘉宏 |
| 國立臺灣大學 |
2015 |
Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection
|
Hsu, Ching-Sheng; Liu, Wei-Liang; Chao, You-Chen; Lin, Hans Hsienhong; Tseng, Tai-Chung; Wang, Chia-Chi; Chen, Ding-Shinn; Kao, Jia-Horng; 陳定信; 高嘉宏 |
Showing items 1-25 of 79 (4 Page(s) Totally)
1 2 3 4 > >>
View [10|25|50] records per page
|
